We evaluated the effects of parasympathetic activation by pyridostigmine (PYR) on chemoreflex sensitivity in a rat model of heart failure (HF rats). HF rats demonstrated higher pulmonary ventilation (PV), which was not affected by PYR. When HF and control rats treated or untreated with PYR were exposed to 15% O 2 , all groups exhibited prompt increases in respiratory frequency (RF), tidal volume (TV) and PV. When HF rats were exposed to 10% O 2 they showed greater PV response which was prevented by PYR. The hypercapnia triggered by either 5% CO 2 or 10% CO 2 promoted greater RF and PV responses in HF rats. PYR blunted the RF response in HF rats but did not affect the PV response. In conclusion, PYR prevented increased peripheral chemoreflex sensitivity, partially blunted central chemoreflex sensitivity and did not affect basal PV in HF rats.
Introduction
Sympathetic overactivity (Liu and Zucker, 1999; Zucker, 2006; Schultz and Li, 2007; Zucker et al., 2012) and reduced vagal drive to the heart Dunlap, 1999, 2011) are hallmarks of heart failure (HF) at the clinical and experimental levels. This cardiac autonomic imbalance is related to an increase in central sympathetic outflow involving central neurotransmitters as nitric oxide and angiotensin II (Zucker and Liu, 2000) and to abnormalities in the cardiorespiratory reflexes, including attenuation of the baroreflex and the cardiopulmonary reflex, which are sympatho-inhibitory reflexes (Wang et al., 1991; Mancia et al., 1992) . Further changes in autonomic control involve an increase in the sympatho-excitatory reflexes, including the chemoreflex and the cardiac sympathetic afferent reflexes (Zhu et al., 2002; Schultz and Li, 2007; Zucker et al., 2012) . Peripheral arterial chemoreceptors are situated in the carotid sinus and aortic arch (Chugh et al., 1996) while central chemoreceptors are located on the ventral surface of the medulla (Schultz and Sun, 2000) . The peripheral chemoreflex is stimulated by decreased fractional inspired O 2 (Guyenet, 2000) , while the increased fractional inspired CO 2 triggers both the central and the peripheral chemoreceptor activity (Lahiri and Forster, 2003; Blain et al., 2010) . Our laboratory has previously demonstrated that hypercapnia induced by 10% of CO 2 in inspired air elicits a hyperventilation that does not involve peripheral chemoreceptors in conscious rats (Sabino et al., 2013b) .
Heart failure leads to an increase in peripheral chemoreflex sensitivity and has been well-documented in rats (Reddy et al., 2007; Wang et al., 2008) , rabbits (Sun et al., 1999; Ding et al., 2011) and patients Ponikowski et al., 2001 ). In addition, Ponikowski et al. (2001) have shown that augmented peripheral chemoreflex sensitivity is an independent predictor of mortality in HF patients. Likewise, previous studies have shown enhanced central chemoreflex sensitivity in HF patients (Narkiewicz et al., 1999; Ueno et al., 2004; Yamada et al., 2004) . However, experimental studies have demonstrated that HF does not alter the central chemoreflex sensitivity of rabbits (Sun et al., 1999) and anesthetized rats (Kristen et al., 2002) .
Sympathetic hyperactivity has been thoroughly investigated in HF (Liu and Zucker, 1999; Zucker, 2006; Schultz and Li, 2007) , and pharmacological approaches targeting the cardiac sympathetic drive are being developed to treat this disease (Bibevski and Dunlap, 2011) . However, the reduced cardiac vagal tone in HF has not received the same attention. Nevertheless, recent studies have demonstrated that vagal stimulation prevents pump failure (De Ferrari et al., 2011) and inhibits HF-related cardiac remodeling and arrhythmias, improving long-term survival in animals with chronic HF (Li et al., 2004; Zheng et al., 2005; Zhang et al., 2009) . Therefore, an increase in parasympathetic function may be an alternative therapeutic approach preventing at least a fraction of the outcomes of HF.
Chemoreflex sensitivity is impaired by electrical stimulation of the distal cut end of glossopharyngeal and/or carotid sinus nerves in normal animals (Eyzaguirre and Koyano, 1965; Fidone and Sato, 1970; Campanucci and Nurse, 2007) , demonstrating the influence of parasympathetic drive on peripheral chemoreceptors. However, the effect of parasympathetic stimulation on the enhanced chemoreflex sensitivity in situations such as HF has not been investigated.
Pyridostigmine bromide (PYR) promotes increase of parasympathetic neurotransmission by inhibiting, peripherally, the enzymatic breakdown of acetylcholine at cholinergic receptor sites (Taylor, 2001; Androne et al., 2003) . Moreover, PYR treatment shows indirect signals of enhanced parasympathetic activity, such as bradycardia and higher HR variability in rats (Soares et al., 2004) , healthy humans (Nobrega et al., 2001) , and patients with HF (Behling et al., 2003) .
Our laboratory has demonstrated a protective effect of PYR on cardiac autonomic control, systolic arterial pressure variability and baroreflex sensitivity, due to an increase in parasympathetic function, 6-7 weeks after the onset of HF in rats (Sabino et al., 2013a) . However, to the best of our knowledge, no study has investigated the effect of PYR on the well-documented enhanced peripheral and central chemoreflex sensitivity observed in HF.
Therefore, the aim of the current study was to evaluate in HF rats the effect of pharmacological activation of parasympathetic function by PYR on the peripheral chemoreflex by examining the respiratory responses to hypoxia and to elucidate the effect of PYR on the central chemoreflex by examining the respiratory responses to hypercapnia. In addition, the current study examines in HF rats the effect of PYR on baseline mean arterial pressure (MAP), heart rate (HR), respiratory frequency (RF), tidal volume (TV), pulmonary ventilation (PV) and cardiac function.
Methods
Experiments were performed on male Wistar rats (280 to 300 g) housed individually with free access to food and water and maintained on a 12:12 h light-dark cycle. All experimental procedures were carried out in accordance with the Guide for the Care and Use of Laboratory Animals 
Surgical procedures
Six to seven weeks before the experiments, the animals were anesthetized with a mixture of ketamine (50 mg/kg, ip União Química Farmacêutica Nacional S/A, Embu-Guaçu, SP, Brazil) and xylazine (10 mg/kg, ip Hertape Calier Saúde Animal S/A, Juatuba, MG, Brazil) and were endotracheally intubated and mechanically ventilated with a respirator (Harvard Apparatus Rodent Respirator, Model 680, Holliston, MA, USA). Heart failure was produced by coronary artery ligation as previously described by Pfeffer et al. (1979) . Briefly, a left thoracotomy was performed through the fifth intercostal space, the pericardium was opened and the heart was externalized. The left anterior descending coronary artery was subsequently ligated with polyester suture (4-0: Ethicon, São José dos Campos, SP, Brazil). The heart was brought back to the thoracic cavity, and the incision was sutured closed. The infarct size was confirmed by post-mortem examination, and only rats with infarct size N 40% of the left ventricular wall were used in the study. Sham-operated control rats underwent a similar surgical procedure without coronary ligation. At the end of the surgery, the animals received analgesic (flunixin meglumine, 2.5 mg/kg, sc) and were maintained in the animal care facility of the Department of Physiology at the School of Medicine of Ribeirão Preto. For three days following the surgical procedure, the animals were treated with analgesic daily (flunixin meglumine, 2.5 mg/kg, sc). The animals were subsequently housed for six to seven weeks until data collection. During this period, they received pure water or PYR (Valeant Farmacêutica do Brasil Ltda, Campinas, SP, Brazil) dissolved in drinking water (0.14 mg/mL). The consumption of water ranged from 53 to 55 mL/rat/day and did not differ among groups. Therefore, the dose of PYR was approximately 22 mg/kg/day in either Sham-operated or infarcted rats. This dose of PYR was based on a previous study by our laboratory (Sabino et al., 2013a) . Two days before the experiments, the rats were anesthetized with a mixture of ketamine (50 mg/kg, ip União Química Farmacêutica Nacional S/A, Embu-Guaçu, SP, Brazil) and xylazine (10 mg/kg, ip Hertape Calier Saúde Animal S/A, Juatuba, MG, Brazil) and instrumented with polyethylene catheters into the femoral artery for direct measurement of arterial pressure (AP). The catheters were tunneled subcutaneously and exteriorized in the nape of the neck, and the surgical incision sites were sutured. The animals were allowed to recover in individual cages until the end of the experimental protocol.
Measurement of arterial pressure
The arterial catheter was connected to a pressure transducer (MLT0380/D, ADInstruments, Sydney, Australia), and the AP signal was amplified (ML110, ADInstruments, Sydney, Australia), fed to an IBM/PC connected to a Power Lab (ML866, ADInstruments, Sydney, Australia) and continuously sampled (2 kHz). MAP and HR were calculated from the pulsatile arterial pressure.
Measurement of respiratory parameters
Respiration was studied by unrestrained whole-body plethysmography (Bartlett and Tenney, 1970) at ambient barometric pressure and at a temperature that matched body core temperature saturated with water vapor (BTPS). The rats were placed into a 5 L Plexiglas chamber (with exit ports for catheters), which allowed them to move freely. Various gas mixtures were allowed to easily pass through the chamber to change the gas concentration. The gas concentration inside the chamber was continuously monitored by an O 2 analyzer (GasAlertMax XT, Canada) and a CO 2 analyzer (microCapStar CO 2 Monitor, PA, USA). The chamber was sealed, except for the inlet and outlet ports that allowed continuous flow of air. A flowmeter gas mixing pump (Cameron, Canada) allowed the injection of various gas concentrations into the chamber. To measure the respiratory parameters, airflow through the chamber was interrupted for a short time (1 min), and the inlet and outlet ports were sealed. Pressure oscillations caused by respiratory movements were detected by a differential pressure transducer (ML141, ADInstruments, Sydney, Australia) and were digitally recorded in an IBM/PC connected to a PowerLab System (ML866, ADInstruments, Sydney, Australia). Volume calibration was achieved during each measurement by injecting a known volume (1 mL) of air into the chamber. Tidal volume (TV) was calculated offline using the formula described by Bartlett and Tenney (1970) . Respiratory frequency (RF) was calculated from the excursion of the TV signal using an average cyclic rate built into the computer software LabChart v7.2 (ADInstruments, Sydney, Australia). Pulmonary ventilation (PV) was calculated as the product of TV and RF.
Experimental protocol
The experimental protocol was adapted from a previous study in our laboratory (Sabino et al., 2013b) . Each animal was individually placed into the plethysmographic chamber at 25°C and was allowed to move freely while the chamber was flushed with humidified air (21% O 2 , 79% N 2 , 1.2 L/min) for 40-50 min, which allowed for acclimatization. After the measurement of baseline respiratory parameters and arterial pressure, each animal was submitted to 2 levels of hypoxia (15% O 2 and 10% O 2 ) and 2 levels of combined hypercapnia and hyperoxia (5% CO 2 + 26% O 2 and 10% CO 2 + 31% O 2 ). The order of each episode of hypoxia and hypercapnia was chosen randomly, and episodes were spaced 20 min apart.
Hypoxia was achieved by flushing 100% N 2 through the chamber. Nitrogen flow was adjusted to 1.6 or 3.5 L/min to achieve 15% O 2 or 10% O 2 inside the chamber within 45 s. Hypercapnia plus hyperoxia at either 5% CO 2 + 26% O 2 or 10% CO 2 + 31% O 2 was also achieved within 45 s by flushing the chamber with 50% CO 2 and 50% O 2 at 1.1 or 1.8 L/min, respectively. Each period of chemoreceptor stimulation was maintained for 1 min, while the respiratory parameters were measured. The chamber was then immediately opened to atmospheric air, and the animals were allowed to recover for 20 min. The following day, the rats were anesthetized with sodium pentobarbital (40 mg/kg ip, Rhobifarma Indústria Farmacêutica Ltda, Hortolândia, SP, Brazil), and a Mikro-Tip pressure catheter (SPR-407, Millar Instruments; Houston, TX, USA) was inserted into the right carotid artery and advanced into the left ventricle (LV) as described elsewhere (Pacher et al., 2008) . After stabilization of hemodynamic parameters, the ventricular pressure was recorded by an IBM/PC attached to an analogic-to-digital interface (PowerLab/4SP, ADInstruments, Mountain View, CA, USA). The LV end-diastolic pressure (LVEDP), maximal slope of systolic pressure increment (+dP/dt_max) and diastolic pressure decrement (−dP/dt_max) were calculated using the built-in blood pressure module of the LabChart v7.2 software (ADInstruments, Mountain View, CA, USA). After the recordings were obtained, the heart and lungs were rapidly removed under anesthesia. The organs were subsequently rinsed in ice-cold 0.9% NaCl solution and weighed. The heart ventricles were cut transversely into two parts to be used for infarct analysis. Cardiac hypertrophy was evaluated by cardiac weight index (heart weight/body weight ratio), and pulmonary edema was evaluated by lung weight index (lung weight/body weight ratio).
Morphological analysis
After transversely cutting the heart, the section containing the apex was fixed in phosphate-buffered 10% formalin and stained with picrosirius red (to assess infarct size). The remaining heart section was fixed in phosphate-buffered 10% formalin and submitted to paraffin inclusion. Each block was cut into 7-μm serial sections beginning at the midventricular surface. The sections were stained with picrosirius red for the analysis of the infarct size. The thickness of the left ventricular wall and the infarct size were measured using the public-domain software NIH Image J (developed by U.S. National Institutes of Health and available on the site http://rsb.info.nih.gov/ nih-image). The infarct size was calculated by dividing the length of infarcted area by the total circumference of the LV and was expressed as a percentage.
Statistical analysis
The results are expressed as the mean ± standard error of the mean (SEM). The basal values (MAP, HR, RF, TV and PV) and changes in response to hypoxia and hypercapnia (ΔRF, ΔTV and ΔPV) were evaluated using two-way ANOVA followed by the Tukey post-test. Differences were considered statistically significant for P b 0.05.
Results

Animal characteristics
Body weight was similar among groups, while heart and lung weight indices were higher in HF rats compared to sham-operated control rats (Table 1) . Infarcted areas were similar between HF rats treated with PYR and HF rats given water alone (Table 1) .
Basal hemodynamics, respiratory parameters and cardiac function
HF rats treated with PYR or water alone exhibited lower MAP but similar HR compared to their sham-operated counterparts (Table 2) . Baseline values of RF and TV were not statistically different among groups. PV was higher in HF rats treated with water but was normal in HF rats treated with PYR compared to sham-operated rats treated or untreated with PYR. HF led to lower + dP/dt max and − dP/dt max and higher LVEDP, and PYR did not affect these parameters (Table 3) .
Respiratory responses to various levels of hypoxia and hypercapnia
Hypoxia at either 15% O 2 or 10% O 2 elicited a prompt and marked rise in RF, TV and PV (Fig. 1) . Nevertheless, the respiratory responses to hypoxia at 15% O 2 were similar in sham-operated and HF rats treated or untreated with PYR. Increases in RF and TV with a stronger hypoxic stimulus (10% O 2 ) were similar in all groups studied. Nevertheless, PV (the product of RF and TV) was higher in HF rats treated with water compared to sham-operated control rats, and PYR prevented this increase (Fig. 1) .
Changes in respiratory parameters elicited by the two levels of hypercapnia are shown in Fig. 2 . Hypercapnia due to either 5% CO 2 or 10% CO 2 caused a prompt and marked increase in all respiratory parameters (Fig. 2) . HF rats demonstrated a greater RF response than sham-operated control rats exposed to either 5% CO 2 or 10% CO 2 . PYR prevented this increased response in HF rats (Fig. 2) . The increase in TV elicited by hypercapnia was similar among all groups. PV increased more in HF rats, and PYR did not change this response.
Discussion
The purpose of the current study was to evaluate the effect of PYR, an acetylcholinesterase inhibitor, on peripheral and central chemoreflex sensitivity six to seven weeks after the onset of HF in rats. Physiological stimulus, i.e. rapid changes in inspired concentration of O 2 and/or CO 2 , was used to evaluate chemoreflex sensitivity in the present study. Hypoxia is known to be a stimulus of mainly peripheral chemoreceptors, while hypercapnia is supposed to stimulate both peripheral and central chemoreceptors (Guyenet, 2000; Lahiri and Forster, 2003; Blain et al., 2010) . The results show that long-term (six to seven weeks) administration of PYR was able to prevent the increased peripheral chemoreflex Table 1 Characteristics from heart failure rats and sham-operated control rats.
Control
Heart failure Water (n = 11)
BW (kg) 0.565 ± 0.01 0.566 ± 0.02 0.567 ± 0.01 0.530 ± 0.01 Heart (g) 1.34 ± 0.06 1.34 ± 0.02 2.00 ± 0.05 ⁎ 2.00 ± 0.05 ⁎ Heart/BW (g/kg) 2.37 ± 0.04 2.29 ± 0.04 3.64 ± 0.06 ⁎ 3.74 ± 0.05 ⁎ Lung (g) 1.38 ± 0.08 1.25 ± 0.06 1.86 ± 0.06 ⁎ 1.89 ± 0.09 ⁎ Lung/BW (g/kg) 2.45 ± 0.13 2.23 ± 0.10 3.31 ± 0.06 ⁎ 3.57 ± 0.17 ⁎ IS (%) --50.2 ± 1.4 ⁎ 48.9 ± 1.9 ⁎ BW: body weight; IS: infarct size; PYR: pyridostigmine. ⁎ P b 0.05 compared to sham-operated control rats.
Table 2
Basal hemodynamics and respiratory parameters from heart failure rats and sham-operated control rats.
Control
Heart failure Water (n = 10) PYR (n = 7) Water (n = 7) PYR (n = 7) MAP (mm Hg) 111 ± 1 113 ± 3 100 ± 3 ⁎ 97 ± 3 ⁎ HR (bpm) 325 ± 10 303 ± 12 307 ± 7 310 ± 7
Water (n = 11) PYR (n = 8) Water (n = 7) PYR (n = 7) RF (cycles/min) 105 ± 6 121 ± 5 128 ± 9 122 ± 10 TV (mL/kg) 4.5 ± 0.2 4.5 ± 0.3 5.1 ± 0.2 4.7 ± 0.3 PV (mL/kg/min) 480 ± 46 541 ± 43 652 ± 31 ⁎ 568 ± 59 MAP: mean arterial pressure; HR: heart rate; RF: respiratory frequency; TV: tidal volume; PV: pulmonary ventilation; PYR: pyridostigmine. ⁎ P b 0.05 compared to sham-operated rats.
sensitivity and partially hampered the increased central chemoreflex sensitivity. Moreover, it is worth noting that to the best of our knowledge, this is the first study to demonstrate that HF increases central chemoreceptor sensitivity in rats. After myocardial infarction, the heart usually adapts through a process known as cardiac remodeling, which involves changes in the structure and function of cardiomyocytes within the non-infarcted myocardium that lead to cardiac hypertrophy (Murdoch et al., 2006) . Additionally, malfunctioning of the cardiac pump promotes an increase in pulmonary capillary pressure, which undoubtedly contributes to the development of pulmonary edema in HF (Luz et al., 1975) . Thus, in the present study, cardiac hypertrophy was evaluated by the cardiac index, and pulmonary edema was evaluated by the lung index. The results show that both cardiac and lung indices were higher in HF rats receiving either water or PYR compared to sham-operated control rats. Therefore, PYR did not normalize the cardiac or the lung indices in a rat model of HF.
PYR also failed to prevent the reduction of MAP and cardiac function parameters (LVEDP, +dP/dt and −dP/dt) in HF rats. These results are in agreement with previous findings from our laboratory that were obtained six to seven weeks after coronary artery ligation in rats (Sabino et al., 2013a) . However, unpublished study from our laboratory failed to show a decrease in MAP four weeks after coronary artery ligation, and PYR improved the ejection fraction and +dP/dt max . Therefore, it is reasonable to hypothesize that MAP reduction is secondary to HF progression and that the beneficial effect of PYR on cardiac function may be confined to a four-week time frame in rats. In addition, electrical stimulation of the vagus nerve fails to prevent hypotension in HF rats (Li et al., 2004) . It might thus be concluded that neither electrical nor pharmacological (PYR) activation of the parasympathetic nervous system is able to prevent the hypotension observed in rats with longterm HF.
The higher ventilatory parameters found in rats with long-term HF in the present study are consistent with previous observations in patients and experimental animals with HF (Sullivan et al., 1988; Li et al., 2006) . However, other studies have shown that basal PV is not altered in HF (Narkiewicz et al., 1999; Sun et al., 1999) . Therefore, Table 3 Cardiac function from heart failure rats and sham-operated control rats. the effect of HF on basal respiratory parameters in patients and experimental animals remains unclear. An increase in peripheral chemoreflex sensitivity has previously been shown in patients Ponikowski et al., 2001) and in experimental models of HF (Ding et al., 2010 (Ding et al., , 2011 . Moreover, Ponikowski et al. (2001) suggested that hypersensitivity of the peripheral chemoreceptors is an independent risk factor for patients with HF. In the present study, hypoxia induced by 15% O 2 elicited similar respiratory responses in HF rats and sham-operated control rats. The stronger hypoxic stimulus (10% O 2 ) revealed an increase in peripheral chemoreceptor sensitivity in HF rats. Pharmacological activation of the parasympathetic nervous system by PYR prevented the increase in PV caused by 10% O 2 hypoxia in HF rats.
In the present study, hypercapnia with either 5% CO 2 or 10% CO 2 promoted greater increases in RF and PV in HF rats compared to sham-operated control rats. The TV response to higher CO 2 levels was similar among all groups. Although there is evidence of increased central chemoreceptor sensitivity in patients (Narkiewicz et al., 1999; Ueno et al., 2004; Yamada et al., 2004) , experimental studies have failed to demonstrate this increase in conscious HF rabbits (Sun et al., 1999) and anesthetized HF rats (Kristen et al., 2002) . The current study is the first to demonstrate increased central chemoreflex sensitivity in HF rats.
PYR prevented the RF increase in HF rats but did not prevent the PV increase. Therefore, it is reasonable to conclude that pharmacological activation of the parasympathetic nervous system only partially prevents the increase in central chemoreflex sensitivity observed in HF rats. It is worth noting that no previous studies have evaluated both central and peripheral chemoreflex sensitivity in HF patients or HF animals after pharmacological or electric activation of the parasympathetic nervous system.
The mechanisms behind the findings of the present study are liked to be related to an increase in parasympathetic drive to carotid body. Treatment with PYR is known to be able to enhance parasympathetic activity in rats (Soares et al., 2004; Sabino et al., 2013a ). An impairment in chemoreflex sensitivity elicited by increased parasympathetic drive to carotid body was demonstrated in normal animals (Fidone and Sato, 1970) . Therefore, PYR might have been able to prevent the enhancement in chemoreflex sensitivity in HF rats due to its effect on parasympathetic activity.
In conclusion, PYR is an important pharmacological approach to protecting physiological mechanisms during the development of HF after coronary artery ligation. Although PYR was unable to prevent the development of HF-related hypotension, cardiac malfunction and increased basal PV, it was remarkably efficient in preventing increases in peripheral chemoreflex sensitivity and partially prevented increases in central chemoreflex sensitivity; both of these increases are typical outcomes of HF. Cientifico e Tecnológico (CNPq) and Coordenadoria de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).
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